You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Fenretinide - d4
Discontinued ProductFenretinide - d4 (Cat. No. 5525) has been withdrawn from sale for commercial reasons.
|Storage||Store at -20°C|
|Isotopic Purity||98% D|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
View Related Products by Target
Keywords: Fenretinide - d4, Fenretinide - d4 supplier, Deuterated, stable, isotope, isotopically, labeled, Fenretinided4, Stable, Isotopically, Labeled, Compounds, 5525, Tocris Bioscience
1 Citation for Fenretinide - d4
Citations are publications that use Tocris products. Selected citations for Fenretinide - d4 include:
Orienti et al (2019) A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells. J Exp Clin Cancer Res 38 373 PMID: 31439019
Reviews for Fenretinide - d4
There are currently no reviews for this product. Be the first to review Fenretinide - d4 and earn rewards!
Have you used Fenretinide - d4?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
New Product Guide [Spring/Summer 2019]
Our new product guide highlights over 215 new products added to the Tocris Bioscience range during the first half of 2019.
- 7-TM Receptors
- Enzyme-Linked Receptors
- Ion Channels
- Nuclear Receptors
- Fluorescent Imaging
- Signal Transduction
- Stem Cells